Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
28 juil. 2021 08h00 HE | ARCA biopharma, Inc.
Analysis in full patient cohort shows Gencaro effect compared to standard of careIn the GENETIC-AF entire cohort of heart failure patients treated with Gencaro, compared to patients treated with...
Bio-Sig-Logo-horiz.jpg
BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention
20 juil. 2021 14h00 HE | BioSig Technologies, Inc.
Westport, CT, July 20, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology
13 juil. 2021 14h30 HE | BioSig Technologies, Inc.
Westport, CT, July 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care
12 juil. 2021 10h30 HE | BioSig Technologies, Inc.
Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- Company to present results from PURE EP 2.0 Study - a multi-center, blinded, and randomized clinical trialLeading physicians evaluated signal data...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Closing of Public Offering of Common Stock
07 juil. 2021 16h10 HE | BioSig Technologies, Inc.
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology
07 juil. 2021 09h36 HE | BioSig Technologies, Inc.
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Pricing of Public Offering of Common Stock
02 juil. 2021 08h15 HE | BioSig Technologies, Inc.
Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Proposed Public Offering of Common Stock
01 juil. 2021 16h05 HE | BioSig Technologies, Inc.
Westport, CT, July 01, 2021 (GLOBE NEWSWIRE) --   BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
30 juin 2021 09h35 HE | BioSig Technologies, Inc.
Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) -- The Company recently increased its procedural volume targets due to accelerated technology usageBioSig expands its commercial team to target...
Bio-Sig-Logo-horiz.jpg
BioSig’s Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat
28 juin 2021 09h45 HE | BioSig Technologies, Inc.
Westport, CT, June 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...